Because elevated expression of EDB-FN is associated with cancer EMT, angiogenesis, and invasion, MT218-MRMI shows promise for detection and characterization of cancer as well as non-invasive assessment of tumor response to RNA based therapies, including RGD-ELNP/miR-200c, across various cancer types [28, 63]. Here, FN1 is linked to cancer.